| Literature DB >> 33437608 |
Miriam Rahhal-Ortuño1, Alex-Samir Fernández-Santodomingo1, Carla Villena-Alvarado1, Emma Marín-Payá1, Marina Aguilar-González1, Salvador García-Delpech1.
Abstract
Cyclosporine 0.1% was used in a patient with Lyell syndrome, which had undergone a KeraKlear® keratoprosthesis implant due to the severe ocular involvement to avoid overuse of corticoid agents. To the best of our knowledge, this is the first reported case of cyclosporine 0.1% eye drops to use in Lyell syndrome previously treated with keratoprosthesis implant. Copyright:Entities:
Keywords: Cyclosporine 0.1%; KeraKlear; Lyell syndrome; keratoprosthesis
Year: 2020 PMID： 33437608 PMCID： PMC7787086 DOI： 10.4103/tjo.tjo_1_20
Source DB: PubMed Journal: Taiwan J Ophthalmol ISSN： 2211-5056